Cannabis and Opioid Use Disorder, Study 2
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorUniversity of Kentucky
About this trial
This inpatient study enrolls healthy individuals who have opioid use disorder. Participants live at the University of Kentucky Hospital for approx. 6 weeks. During this time, we will examine how repeated doses of oral cannabis and acute doses of oral and inhaled cannabis 1) modify the intensity and time course of opioid withdrawal, 2) modify the effects of intranasal opioid administration and 3) impact the safety of opioid administration.
Eligibility criteria
Qualifiers
Participants with moderate to severe opioid use disorder
Disqualifiers
Individuals who do not use opioids or do not experience opioid withdrawal when they stop using opioids
Trial design
Treatments tested in this trial
- Inhaled Cannabis
- Intranasal Opioid
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov